top of page
Search

Equity Considerations in Injury Compensation

I had the great opportunity today to address the National Academies of Science, Engineering, and Medicine’s committee on Equity Considerations in Injury Compensation. I discussed my more than 20 years experience in the National Vaccine Injury Compensation Program, how the NVICP evolved and how Congress’ failure to modernize the Program is causing crushing delays.


#JusticedelayedisJusticedenied

1 view0 comments

Recent Posts

See All

Unfortunately, they're exactly what we expected. There was one payout for anaphylaxis ($2,019.55), and two myocarditis ($1,582.65 and $1,032.69). You can track the awards here. The CICP is not a reaso

bottom of page